We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Santhera Enrolls Last Patient in RHODOS Study Evaluating Catena® in Leber's Hereditary Optic Neuropathy

News   Aug 07, 2009

 
Santhera Enrolls Last Patient in RHODOS Study Evaluating Catena® in Leber's Hereditary Optic Neuropathy
 
 
Advertisement
 

RELATED ARTICLES

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant

News

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

Gut Bacteria May Be Responsible for Adverse Effect of Parkinson's Drug

News

Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson's disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE